Form 4 for RVTY Revvity
Accepted 2026-02-06 00:00:00 ET · period of report 2026-02-04 · accession 0001193125-26-041158 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-02-06 | 2026-02-04 | RVTY | Singh Prahlad R. | Please See Remarks, Dir | F - Tax | $101.13 | -3,421 | 93.4K | -4% | -$346.0K |
| DMT | 2026-02-06 | 2026-02-05 | RVTY | Singh Prahlad R. | Please See Remarks, Dir | S - Sale+OE | $100.21 | -25.5K | 121.3K | -17% | -$2.56M |
| DT | 2026-02-06 | 2026-02-05 | RVTY | Singh Prahlad R. | Please See Remarks, Dir | M - OptEx | $92.09 | +25.5K | 145.7K | +21% | +$2.35M |
| DT | 2026-02-06 | 2026-02-04 | RVTY | Singh Prahlad R. | Please See Remarks, Dir | A - Grant | $0.00 | +26.8K | 120.2K | +29% | $0 |
| DT | 2026-02-06 | 2026-02-04 | RVTY | Singh Prahlad R. | Please See Remarks, Dir | A - Grant | $0.00 | +76.6K | 76.6K | New | $0 |
| DT | 2026-02-06 | 2026-02-05 | RVTY | Singh Prahlad R. | Please See Remarks, Dir | M - OptEx | $0.00 | -25.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-04 | F | D | 3,421 | $101.13 | 93,417 | D | — | — | (F1) The vesting schedule for the restricted stock unit grant to the Reporting Person included in the Form 4 filed on February 6, 2025 was incorrectly reported due to administrative error. The restricted stock unit grant included in that Form 4 is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. (F2) These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 4, 2025, as required by the Reporting Person's Restricted Stock Unit Agreement. |
| 2 | Common | Common Stock | 2026-02-05 | S | D | 7,885 | $100.63 | 124,360 | D | — | — | (F7) The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $100.10 to $101.09. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2026-02-05 | S | D | 12,186 | $99.55 | 132,245 | D | — | — | (F6) The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $99.10 to $100.08. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2026-02-05 | S | D | 1,307 | $99.02 | 144,431 | D | — | — | (F5) The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $98.98 to $99.07. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2026-02-05 | M | A | 25,525 | $92.09 | 145,738 | D | — | — | |
| 6 | Common | Common Stock | 2026-02-05 | S | D | 1,068 | $102.52 | 120,213 | D | — | — | (F9) The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $102.18 to $103.03. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2026-02-05 | S | D | 3,079 | $101.45 | 121,281 | D | — | — | (F8) The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $101.12 to $101.93. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 8 | Common | Common Stock | 2026-02-04 | A | A | 26,796 | $0.00 | 120,213 | D | — | — | (F3) Shares are time-based restricted stock units that are scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. |
| 9 | Derivative | NQ Stock Option (right to buy) | 2026-02-04 | A | A | 76,647 | $0.00 | 76,647 | D | $103.40 · — to 2033-02-04 | 76,647 Common Stock | (F11) This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. |
| 10 | Derivative | NQ Stock Option (right to buy) | 2026-02-05 | M | D | 25,525 | $0.00 | 0 | D | $92.09 · — to 2026-02-05 | 25,525 Common Stock | (F12) This option became exercisable in three equal annual installments beginning on February 5, 2020, which was the first anniversary of the date on which the option was granted. |